{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:15:35Z","timestamp":1761743735296,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.brachy.2012.07.002","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T13:05:57Z","timestamp":1360760757000},"page":"375-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["First report on the use of a thinner 125I radioactive seed within 20-gauge needles for permanent radioactive seed prostate brachytherapy: Evaluation of postimplant dosimetry and acute toxicity"],"prefix":"10.1016","volume":"12","author":[{"given":"John","family":"Sylvester","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devi","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Bilik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2012.07.002_bib1","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/01.ju.0000154633.73092.8e","article-title":"12-Year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer","volume":"173","author":"Potters","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2012.07.002_bib2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0360-3016(00)00550-2","article-title":"Five year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer","volume":"47","author":"Zelefsky","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijrobp.2006.07.1382","article-title":"15-Year biochemical relapse free survival in clinical stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience","volume":"67","author":"Sylvester","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib4","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ijrobp.2004.01.023","article-title":"Combined modality treatment in the management of high-risk prostate cancer","volume":"59","author":"Stock","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0167-8140(00)00288-7","article-title":"The role of external beam radiotherapy with I-125\/Pd-103 brachytherapy for prostate carcinoma","volume":"57","author":"Blasko","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2012.07.002_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0360-3016(99)00499-X","article-title":"Palladium-103 brachytherapy for prostate carcinoma","volume":"46","author":"Blasko","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(01)01601-7","article-title":"10-Year biochemical (prostate specific antigen) control of prostate cancer with (125) I brachytherapy","volume":"51","author":"Grimm","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-5347(05)65970-8","article-title":"Long-term treatment related complications of brachytherapy for early prostate cancer: A survey of patients previously treated","volume":"166","author":"Talcott","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2012.07.002_bib9","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.juro.2009.12.102","article-title":"Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer","volume":"183","author":"Malcolm","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2012.07.002_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0022-5347(05)65870-3","article-title":"Quality of life after treatment for localized prostate cancer: Differences based on treatment modality","volume":"166","author":"Davis","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2012.07.002_bib11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1118\/1.3056463","article-title":"Monte Carlo radiation dose simulations and dosimetric comparison of the model 6711 and model 9011 I125 brachytherapy sources","volume":"36","author":"Rivard","year":"2009","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib12","unstructured":"Roberts G, Al Qaisieh B, Bownes P. What impact would the use of 125I OncoSeed model 9011 source instead of 6711 have on dosimetry and visibility for permanent prostate brachytherapy? Abstract 12, Available at: www.prostatebrachytherapy.org.uk. UK and Ireland Conference\u00a02010. Accessed 1 March 2012."},{"key":"10.1016\/j.brachy.2012.07.002_bib13","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1118\/1.3360899","article-title":"Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source","volume":"37","author":"Kennedy","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1096-9098(199709)66:1<65::AID-JSO13>3.0.CO;2-N","article-title":"Interstitial implantation techniques in prostate cancer","volume":"66","author":"Sylvester","year":"1997","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.brachy.2012.07.002_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brachy.2008.02.471","article-title":"Permanent prostate brachytherapy preplanned technique: The modern Seattle method step by step and dosimetric outcomes","volume":"7","author":"Sylvester","year":"2008","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2012.07.002_bib16","series-title":"Image-guided diagnosis and treatment of cancer","first-page":"119","article-title":"Transrectal ultrasound guided prostate brachytherapy image guided diagnosis and treatment of cancer","author":"Sylvester","year":"2003"},{"key":"10.1016\/j.brachy.2012.07.002_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(98)00006-6","article-title":"A dose-response study for I-125 prostate implants","volume":"41","author":"Stock","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2005.06.035","article-title":"The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy","volume":"64","author":"Niehaus","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0360-3016(01)02812-7","article-title":"Predictive factors of urinary retention following prostate brachytherapy","volume":"53","author":"Bucci","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib20","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0022-5347(01)62542-4","article-title":"Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate","volume":"160","author":"Terk","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2012.07.002_bib21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0360-3016(01)02657-8","article-title":"Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study","volume":"52","author":"Locke","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1538-4721(03)00100-4","article-title":"Celecoxib to decrease urinary retention associated with prostate brachytherapy","volume":"2","author":"Feigenberg","year":"2003","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2012.07.002_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0360-3016(99)00525-8","article-title":"Temporal resolution of urinary morbidity following prostate brachytherapy","volume":"47","author":"Merrick","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2004.04.054","article-title":"Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy","volume":"61","author":"Schwartz","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib25","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.ijrobp.2004.01.041","article-title":"Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity","volume":"59","author":"Eapen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0360-3016(00)00784-7","article-title":"Factors predicting for post implantation urinary retention after permanent prostate brachytherapy","volume":"48","author":"Lee","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijrobp.2005.04.056","article-title":"Decline in urinary retention incidences in 805 patients after prostate brachytherapy: The effect of learning curve","volume":"64","author":"Keyes","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib28","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ijrobp.2004.01.045","article-title":"Acute urinary retention after transperineal template guided prostate biopsy","volume":"59","author":"Buskirk","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib29","first-page":"117","article-title":"Influence of prophylactic dexamethasone on edema following prostate brachytherapy","volume":"6","author":"Merrick","year":"2000","journal-title":"Tech Urol"},{"key":"10.1016\/j.brachy.2012.07.002_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1078-1439(00)00100-9","article-title":"Early voiding dysfunction associated with prostate brachytherapy","volume":"6","author":"Wagner","year":"2000","journal-title":"Urol Oncol"},{"key":"10.1016\/j.brachy.2012.07.002_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0360-3016(01)01473-0","article-title":"A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy","volume":"50","author":"Potters","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib32","first-page":"94","article-title":"Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion","volume":"62","author":"Tausky","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijrobp.2005.06.044","article-title":"Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds","volume":"64","author":"McLaughin","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2012.07.002_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1538-4721(02)00058-2","article-title":"Prostate gland motion and deformation caused by needle placement during brachytherapy","volume":"1","author":"Stone","year":"2002","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2012.07.002_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0167-8140(00)00162-6","article-title":"Seed misplacement and stabilizing needles in transperineal permanent prostate implants","volume":"55","author":"Taschereau","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2012.07.002_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00002820-199704000-00002","article-title":"Validity of a verbally administered numeric rating scale to measure cancer pain intensity","volume":"20","author":"Paice","year":"1997","journal-title":"Cancer Nurs"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472113000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472113000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:06:55Z","timestamp":1761530815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472113000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1538472113000068"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2012.07.002","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First report on the use of a thinner 125I radioactive seed within 20-gauge needles for permanent radioactive seed prostate brachytherapy: Evaluation of postimplant dosimetry and acute toxicity","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2012.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}